TY  - GEN
AU  - Bigot,Pierre
AU  - Fardoun,Tarek
AU  - Bernhard,Jean Christophe
AU  - Xylinas,Evanguelos
AU  - Berger,Julien
AU  - Rouprêt,Morgan
AU  - Beauval,Jean-Baptiste
AU  - Lagabrielle,Samuel
AU  - Lebdai,Souhil
AU  - Ammi,Myriam
AU  - Baumert,Hervé
AU  - Escudier,Bernard
AU  - Grenier,Nicolas
AU  - Hétet,Jean-François
AU  - Long,Jean-Alexandre
AU  - Paparel,Philippe
AU  - Rioux-Leclercq,Nathalie
AU  - Soulié,Michel
AU  - Azzouzi,Abdel-Rahmène
AU  - Bensalah,Karim
AU  - Patard,Jean-Jacques
TI  - Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
SN  - 1433-8726
PY  - 2014///1006
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - epidemiology
KW  - Combined Modality Therapy
KW  - Comorbidity
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - France
KW  - Humans
KW  - Indoles
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Neoadjuvant Therapy
KW  - Nephrectomy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Pyrroles
KW  - Retrospective Studies
KW  - Sorafenib
KW  - Sunitinib
KW  - Thrombectomy
KW  - Thrombosis
KW  - Treatment Outcome
KW  - Vena Cava, Inferior
KW  - surgery
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00345-013-1088-1
ER  -